Concurrent Investment Advisors LLC Has $2.07 Million Stock Holdings in The Allstate Co. (NYSE:ALL)

Concurrent Investment Advisors LLC boosted its stake in The Allstate Co. (NYSE:ALL) by 1.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,723 shares of the insurance provider’s stock after purchasing an additional 139 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in Allstate were worth $2,067,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Advyzon Investment Management LLC bought a new stake in Allstate in the fourth quarter valued at about $242,000. Handelsbanken Fonder AB increased its holdings in Allstate by 3.0% in the fourth quarter. Handelsbanken Fonder AB now owns 58,640 shares of the insurance provider’s stock valued at $11,305,000 after purchasing an additional 1,683 shares during the last quarter. Ieq Capital LLC increased its holdings in Allstate by 71.9% in the fourth quarter. Ieq Capital LLC now owns 17,048 shares of the insurance provider’s stock valued at $3,287,000 after purchasing an additional 7,133 shares during the last quarter. Private Advisor Group LLC increased its holdings in Allstate by 40.4% in the fourth quarter. Private Advisor Group LLC now owns 17,840 shares of the insurance provider’s stock valued at $3,439,000 after purchasing an additional 5,130 shares during the last quarter. Finally, TimesSquare Capital Management LLC increased its holdings in Allstate by 3.8% in the fourth quarter. TimesSquare Capital Management LLC now owns 425,978 shares of the insurance provider’s stock valued at $82,124,000 after purchasing an additional 15,650 shares during the last quarter. Institutional investors own 76.47% of the company’s stock.

Insider Activity at Allstate

In related news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the transaction, the chief financial officer now directly owns 18,115 shares of the company’s stock, valued at approximately $3,378,990.95. This represents a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.80% of the company’s stock.

Allstate Stock Down 1.9 %

NYSE:ALL opened at $185.51 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36. The company has a market cap of $49.12 billion, a PE ratio of 10.92, a PEG ratio of 1.05 and a beta of 0.52. The Allstate Co. has a 52-week low of $153.87 and a 52-week high of $209.88. The stock has a 50-day simple moving average of $190.25 and a 200 day simple moving average of $190.15.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 EPS for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. On average, sell-side analysts expect that The Allstate Co. will post 18.65 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Barclays dropped their price objective on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a report on Monday, January 6th. UBS Group increased their price target on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Morgan Stanley increased their price target on Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a report on Thursday, November 7th. Wells Fargo & Company increased their price target on Allstate from $186.00 to $187.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 14th. Finally, Keefe, Bruyette & Woods increased their price target on Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a report on Tuesday, February 11th. One research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $217.94.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.